Philips has launched its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe to enhance access to minimally invasive heart procedures.
VeriSight Pro allows real-time 3D imaging inside the heart to provide physicians with enhanced clarity during procedures without the need for general anaesthesia.
The advanced catheter technology, which has already been launched in the US, is designed for procedures such as transcatheter valve repair and left atrial appendage closure.
It provides high-resolution 2D and 3D visualisation within heart chambers, facilitating confident clinical decision-making in structural heart and electrophysiology interventions.
The catheter eliminates the need for general anaesthesia, reducing associated risks.
VeriSight Pro is a part of Philips’ structural heart disease ecosystem, integrating with Philips’ EPIQ ultrasound systems and the Azurion image-guided therapy platform.
Its xPlane and iRotate technologies enable physicians to visualise two imaging planes simultaneously and digitally adjust views without repositioning the catheter tip.
Philips image-guided therapy devices business leader Stacy Beske said: “VeriSight Pro reflects our ongoing commitment to delivering clinically relevant innovations that enhance precision, reduce procedure complexity, and improve the care experience.
“Its availability in Europe is an important milestone in helping more patients benefit from image-guided, minimally invasive heart procedures, while supporting care teams with integrated solutions that adapt to the way they work.”
According to the company, structural heart disease is a growing challenge across Europe, and traditional methods often require general anaesthesia, additional staff, and extended room time.
Unlike traditional methods, 3D ICE imaging provides detailed visualisation from within the heart through a catheter, potentially reducing recovery time and hospital costs.
The VeriSight Pro catheter, featuring a miniaturised ultrasound probe that measures around three millimetres in diameter, is embedded at the tip of a thin, steerable catheter.
The device navigates through the vascular system into heart chambers, delivering high-quality 2D and 3D images in real time.
Also, the catheter allows physicians to assess anatomy, guide device placement, and confirm procedural results from a single access point.
Ludwig-Maximilians-Universität (LMU) Munich, Germany, professor Jörg Hausleiter said: “With VeriSight Pro 3D ICE, we now have the ability to see detailed cardiac anatomy from inside the heart in real time.
“This helps streamline our workflows and makes complex procedures more accessible to patients who may not tolerate more invasive imaging approaches.”
Recently, Philips partnered with NVIDIA to improve scan times, workflow efficiency, and image quality using AI, enabling the delivery of faster and more accurate diagnoses.
